Header Logo

Connection

ELIZABETH HILL to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications ELIZABETH HILL has written about Antibodies, Monoclonal, Humanized.
ELIZABETH HILL
Connection Strength
0.125
Antibodies, Monoclonal, Humanized
  1. Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma. Oncologist. 2021 04; 26(4):288-e541.
    View in: PubMed
    Score: 0.125
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.